These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6199909

  • 1. New approaches for treatment of humans exposed to a slowly excreted environmental chemical (chlordecone).
    Guzelian PS.
    Z Gastroenterol; 1984 Jan; 22(1):16-20. PubMed ID: 6199909
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic approaches for chlordecone poisoning in humans.
    Guzelian PS.
    J Toxicol Environ Health; 1981 Jan; 8(5-6):757-66. PubMed ID: 6175768
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Demonstration of major metabolic pathways for chlordecone (kepone) in humans.
    Fariss MW, Blanke RV, Saady JJ, Guzelian PS.
    Drug Metab Dispos; 1980 Jan; 8(6):434-8. PubMed ID: 6161768
    [Abstract] [Full Text] [Related]

  • 7. Chlordecone poisoning: a case study in approaches for detoxification of humans exposed to environmental chemicals.
    Guzelian PS.
    Drug Metab Rev; 1982 Jan; 13(4):663-79. PubMed ID: 6181951
    [No Abstract] [Full Text] [Related]

  • 8. Cholestyramine: use as a new therapeutic approach for chlordecone (kepone) poisoning.
    Boylan JJ, Egle JL, Guzelian PS.
    Science; 1978 Feb 24; 199(4331):893-5. PubMed ID: 74852
    [Abstract] [Full Text] [Related]

  • 9. High-density lipoproteins decrease the biliary concentration of chlordecone in isolated perfused pig liver.
    Soine PJ, Blanke RV, Chinchilli VM, Schwartz CC.
    J Toxicol Environ Health; 1984 Feb 24; 14(2-3):319-35. PubMed ID: 6209411
    [Abstract] [Full Text] [Related]

  • 10. Neurological manifestations in humans exposed to chlordecone and follow-up results.
    Taylor JR.
    Neurotoxicology; 1982 Oct 24; 3(2):9-16. PubMed ID: 6186968
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chlordecone intoxication in man. I. Clinical observations.
    Taylor JR, Selhorst JB, Houff SA, Martinez AJ.
    Neurology; 1978 Jul 24; 28(7):626-30. PubMed ID: 79155
    [Abstract] [Full Text] [Related]

  • 14. Chlordecone alcohol formation in the Mongolian gerbil (Meriones unguiculatus): a model for human metabolism of chlordecone (kepone).
    Houston TE, Mutter LC, Blanke RV, Guzelian PS.
    Fundam Appl Toxicol; 1981 Jul 24; 1(3):293-8. PubMed ID: 6192032
    [Abstract] [Full Text] [Related]

  • 15. Chlordecone disappearance in tissues of growing goats after a one month decontamination period--effect of body fatness on chlordecone retention.
    Lastel ML, Lerch S, Fournier A, Jurjanz S, Mahieu M, Archimède H, Feidt C, Rychen G.
    Environ Sci Pollut Res Int; 2016 Feb 24; 23(4):3176-83. PubMed ID: 26590062
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of plasma proteins in the transport and distribution of chlordecone (Kepone) and other polyhalogenated hydrocarbons.
    Skalsky HL, Fariss MW, Blanke RV, Guzelian PS.
    Ann N Y Acad Sci; 1979 May 31; 320():231-7. PubMed ID: 88201
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The clinical toxicology of chlordecone as an example of toxicological risk assessment for man.
    Guzelian PS.
    Toxicol Lett; 1992 Dec 31; 64-65 Spec No():589-96. PubMed ID: 1281940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.